Approval · Notice of Compliance 9456 · 2008
SEVOFLO: Notice of Compliance 9456
Issued March 28, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9456
- Date
- March 28, 2008
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anesthetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEVOFLO | 02308355 | Cancelled Pre Market |
Medicinal ingredients
- SEVOFLURANE 100 PER